Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
RFK Jr. Hints FDA Approval of Psychedelic Therapy Hope
Posted
July 29, 2025
Views
1,501
Likes
30
Comments
7
Engagement
2.47%
July 29, 2025
1,501
30
7
2.47%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
10:42Now PlayingRFK Jr. earlier this month said he could envision approval for psychedelic drugs as treatment for depression and trauma if clinical studies have been conducted. Kabir Nath, CEO of Compass Pathways, makers of synthetic psilocybin told Bloomberg Businessweek Daily, his company is conducting clinical studies for the treatment of depression.
--------
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Follow us on X
Subscribe to our Podcasts:
Bloomberg Daybreak
Bloomberg Surveillance
Bloomberg Intelligence
Balance of Power
Bloomberg Businessweek
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay
Android Auto
Visit our YouTube channels:
Bloomberg Podcasts
Bloomberg Television
Bloomberg Originals
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
